Cargando…
Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes
AIMS/HYPOTHESIS: A key unanswered question in type 1 diabetes is whether beta cells initiate their own destruction or are victims of an aberrant immune response (beta cell suicide or homicide?). To investigate this, we assessed islet autoantibodies in individuals with congenital beta cell defects ca...
Autores principales: | Wyatt, Rebecca C., Hagopian, William A., Roep, Bart O., Patel, Kashyap A., Resnick, Brittany, Dobbs, Rebecca, Hudson, Michelle, De Franco, Elisa, Ellard, Sian, Flanagan, Sarah E., Hattersley, Andrew T., Oram, Richard A., Johnson, Matthew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174109/ https://www.ncbi.nlm.nih.gov/pubmed/35501400 http://dx.doi.org/10.1007/s00125-022-05697-3 |
Ejemplares similares
-
Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells
por: Johnson, Matthew B., et al.
Publicado: (2020) -
Islet stress, degradation and autoimmunity
por: Thomaidou, Sofia, et al.
Publicado: (2018) -
Neurogenin 3 is important but not essential for pancreatic islet development in humans
por: Rubio-Cabezas, Oscar, et al.
Publicado: (2014) -
A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes
por: Johnson, Matthew B., et al.
Publicado: (2018) -
Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
por: Huurman, Volkert A. L., et al.
Publicado: (2008)